Supplemental material
Journal of Asthma
Volume 60, 2023 - Issue 9
Open access
1,639
Views
0
CrossRef citations to date
0
Altmetric
Research Articles
Dupilumab long-term efficacy in patients with non–OCS–dependent asthma with and without evidence of allergic asthma
Lawrence D. Shera Peninsula Research Associates, Rolling Hills Estates, CA, USACorrespondence[email protected]
View further author information
, MD, View further author information
Jonathan Correnb David Geffen School of Medicine at UCLA, Los Angeles, CA, USAView further author information
, MD, Ian D. Pavordc NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UKView further author information
, MD, Nadia Daizadehd Sanofi, Cambridge, MA, USAView further author information
, PhD, Arman Altincatald Sanofi, Cambridge, MA, USAView further author information
, MS, Xavier Solere Regeneron Pharmaceuticals Inc, Tarrytown, NY, USAView further author information
, MD, PhD, Michel Djandjid Sanofi, Cambridge, MA, USAView further author information
, MD, Amr Radwane Regeneron Pharmaceuticals Inc, Tarrytown, NY, USAView further author information
, MB, BChir, FFPM, Juby A. Jacob-Naraf Sanofi, Bridgewater, NJ, USAView further author information
, MD, DHSc, MPH, MBA, Yamo Denize Regeneron Pharmaceuticals Inc, Tarrytown, NY, USAView further author information
, MD & Paul J. Rowef Sanofi, Bridgewater, NJ, USAView further author information
, MD, ATSF show all
Pages 1767-1774
|
Received 09 Feb 2023, Accepted 25 Feb 2023, Published online: 31 May 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.